215 related articles for article (PubMed ID: 30943132)
21. Vitamin D Levels in Takayasu's Arteritis and a Review of the Literature on Vasculitides.
Alibaz-Oner F; Asmaz-Haliloglu Ö; Gogas-Yavuz D; Can M; Haklar G; Direskeneli H
J Clin Lab Anal; 2016 Sep; 30(5):529-33. PubMed ID: 26661754
[TBL] [Abstract][Full Text] [Related]
22. Using the co-expression network of T cell-activation-related genes to assess the disease activity in Takayasu's arteritis patients.
Tian Y; Li J; Tian X; Zeng X
Arthritis Res Ther; 2021 Dec; 23(1):303. PubMed ID: 34915894
[TBL] [Abstract][Full Text] [Related]
23. Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu's arteritis.
John RA; Keshava SN; Danda D
Int J Rheum Dis; 2017 Jul; 20(7):882-886. PubMed ID: 28736969
[TBL] [Abstract][Full Text] [Related]
24. Study on Serum Pentraxin-3 Levels in Vasculitis with Hypertension.
Wu T; Zhu B; Zhu Q; Tursun D; Liu S; Liu S; Hu J; Li N
J Interferon Cytokine Res; 2019 Sep; 39(9):522-530. PubMed ID: 31264920
[TBL] [Abstract][Full Text] [Related]
25. Risk assessment model for heart failure in Chinese patients with Takayasu's arteritis.
Wang YJ; Ma LL; Liu Y; Yan Y; Sun Y; Wang YS; Dai XM; Ji ZF; Ma LY; Chen HY; Jiang LD
Clin Rheumatol; 2021 Oct; 40(10):4117-4126. PubMed ID: 34021842
[TBL] [Abstract][Full Text] [Related]
26. AMPK hyperactivity maintains the survival of vasculogenic T cells in patients with Takayasu's arteritis.
Sun M; Zhang X; Hao Y; Yin P; Hu J; Zheng M; Wen Z; Liu X; Wang C
Clin Exp Rheumatol; 2023 Apr; 41(4):902-909. PubMed ID: 36826789
[TBL] [Abstract][Full Text] [Related]
27. Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT.
Alibaz-Oner F; Dede F; Ones T; Turoglu HT; Direskeneli H
Mod Rheumatol; 2015 Sep; 25(5):752-5. PubMed ID: 25671403
[TBL] [Abstract][Full Text] [Related]
28. Presence of fibromyalgia in patients with Takayasu's arteritis.
Alibaz-Oner F; Can M; İlhan B; Polat Ö; Mumcu G; Direskeneli H
Intern Med; 2013; 52(24):2739-42. PubMed ID: 24334577
[TBL] [Abstract][Full Text] [Related]
29. HADS-depression score is a mediator for illness perception and daily life impairment in Takayasu's arteritis.
Erdal S; Nalbantoğlu B; Gür MB; Yıldırım M; Kılıçarslan A; Kaymaz-Tahra S; Alibaz-Öner F; Yay M; Mumcu G; Direskeneli H
Clin Rheumatol; 2021 Oct; 40(10):4109-4116. PubMed ID: 33839991
[TBL] [Abstract][Full Text] [Related]
30. Characteristics of B cells and immunoglobulin profile in Takayasu's arteritis.
Ci W; Li T; Du J; Fang W; Chen D; Han L; Dong R; Cao J; Pan L
Clin Exp Rheumatol; 2023 Apr; 41(4):870-878. PubMed ID: 36533979
[TBL] [Abstract][Full Text] [Related]
31. Lack of antilipoprotein lipase antibodies in Takayasu's arteritis.
de Carvalho JF; Pereira RM; Viana VS; Bonfá E; Shoenfeld Y
Clin Dev Immunol; 2009; 2009():803409. PubMed ID: 19606253
[TBL] [Abstract][Full Text] [Related]
32. Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited.
Keser G; Aksu K; Direskeneli H
Rheumatology (Oxford); 2018 May; 57(5):784-790. PubMed ID: 28968895
[TBL] [Abstract][Full Text] [Related]
33. Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.
Soriano A; Pazzola G; Boiardi L; Casali M; Muratore F; Pipitone N; Catanoso M; Aldigeri R; Cimino L; Versari A; Salvarani C
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):99-106. PubMed ID: 29799393
[TBL] [Abstract][Full Text] [Related]
34. YKL-40 as a new biomarker of disease activity in Takayasu arteritis.
Sun Y; Kong X; Wu S; Ma L; Yan Y; Lv P; Jiang L
Int J Cardiol; 2019 Oct; 293():231-237. PubMed ID: 31303395
[TBL] [Abstract][Full Text] [Related]
35. Validation of the 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis.
Tomelleri A; Padoan R; Kavadichanda CG; Jose A; Singh K; Iorio L; Rathore U; Rinaldi E; Baldissera E; Agarwal V; Dagna L; Campochiaro C; Misra DP
Rheumatology (Oxford); 2023 Oct; 62(10):3427-3432. PubMed ID: 37018125
[TBL] [Abstract][Full Text] [Related]
36. Serum BAFF and APRIL levels in Indian patients with Takayasu arteritis.
Zanwar A; Jain A; Gupta L; Chaurasia S; Kumar S; Misra DP; Misra R
Clin Rheumatol; 2018 Dec; 37(12):3439-3442. PubMed ID: 29998368
[TBL] [Abstract][Full Text] [Related]
37. The feasibility of quantitative assessment of dynamic
Duan Y; Zan K; Zhao M; Ng YL; Li H; Ge M; Chai L; Cui X; Quan W; Li K; Zhou Y; Chen L; Wang X; Cheng Z
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):81-92. PubMed ID: 37691022
[TBL] [Abstract][Full Text] [Related]
38. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
Ramirez GA; Rovere-Querini P; Blasi M; Sartorelli S; Di Chio MC; Baldini M; De Lorenzo R; Bozzolo EP; Leone R; Mantovani A; Manfredi AA; Tombetti E
Front Immunol; 2019; 10():1135. PubMed ID: 31191526
[TBL] [Abstract][Full Text] [Related]
39. Paediatric-onset Takayasu's arteritis associates with worse survival than adult-onset Takayasu's arteritis. A matched retrospective cohort study.
Misra DP; Thakare DR; Mishra P; Rathore U; Singh K; Behera MR; Jain N; Ora M; Bhadauria DS; Gambhir S; Kumar S; Agarwal V
Clin Exp Rheumatol; 2024 Apr; 42(4):914-922. PubMed ID: 37584395
[TBL] [Abstract][Full Text] [Related]
40. Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.
Alibaz-Oner F; Koster MJ; Unal AU; Yildirim HG; Çikikçi C; Schmidt J; Crowson CS; Makol A; Ytterberg SR; Matteson EL; Direskeneli H; Warrington KJ
Rheumatology (Oxford); 2017 Nov; 56(11):1939-1944. PubMed ID: 28968808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
